Skip to main content
. 2020 Jul 6;19:107. doi: 10.1186/s12933-020-01078-5

Fig. 3.

Fig. 3

Crude cumulative incidence plot for the events of hospitalisation for heart failure, composite MACE endpoint (myocardial infarction, stroke, or cardiovascular death), and all-cause mortality. GLP-1 glucagon like peptide-1 receptor agonist, SGLT Sodium–glucose transporter 2 inhibitor, DPP-4 dipeptidyl peptidase 4 inhibitor